We are live on ! Find out more
BBH icon

VanEck Biotech ETF

106 hedge funds and large institutions have $108M invested in VanEck Biotech ETF in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 38 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

8% more funds holding

Funds holding: 98 → 106 (+8)

4.88% less ownership

Funds ownership: 34.76% → 29.87% (-4.9%)

68% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 38

69% less call options, than puts

Call options by funds: $232K | Put options by funds: $746K

75% less capital inflows, than outflows

Capital inflows: $4.8M | Capital outflows: $19.3M

Holders
106
Holders Change
+8
Holders Change %
+8.16%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
38
Closed
3
Calls
$232​K
Puts
$746​K
Net Calls
-⁠$514​K
Net Calls Change
-⁠$146​K

BBH Hedge Fund Activity: Q3 2025 in Review

106 of the 7,660 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2025, worth a combined $108M — down 5.9% from $115M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 3 closed out — a net gain of 10 holders — while 12 added to existing stakes and 38 trimmed.

The largest buyer was Paragon Private Wealth Management, adding an estimated $1.51M. The largest seller was TD Waterhouse Canada, cutting an estimated $10.5M.

  • 106 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2025, up from 98 in Q2 2025.
  • Funds reported $108M of VanEck Biotech ETF stock for Q3 2025, down 5.9% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q3 2025 and 3 closed out, a net change of +10 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2025 was Paragon Private Wealth Management, an estimated $1.51M added.
  • The largest VanEck Biotech ETF seller in Q3 2025 was TD Waterhouse Canada, an estimated $10.5M sold.

Based on aggregated 13F filings for Q3 2025.